These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 27261337)

  • 1. Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett's oesophagus.
    Fock KM; Talley N; Goh KL; Sugano K; Katelaris P; Holtmann G; Pandolfino JE; Sharma P; Ang TL; Hongo M; Wu J; Chen M; Choi MG; Law NM; Sheu BS; Zhang J; Ho KY; Sollano J; Rani AA; Kositchaiwat C; Bhatia S
    Gut; 2016 Sep; 65(9):1402-15. PubMed ID: 27261337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barrett's oesophagus: optimal strategies for prevention and treatment.
    Fass R; Sampliner RE
    Drugs; 2003; 63(6):555-64. PubMed ID: 12656653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review with meta-analysis: risk factors for Barrett's oesophagus in individuals with gastro-oesophageal reflux symptoms.
    Eusebi LH; Telese A; Cirota GG; Haidry R; Zagari RM; Bazzoli F; Ford AC
    Aliment Pharmacol Ther; 2021 May; 53(9):968-976. PubMed ID: 33705573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
    Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
    Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokeratin 7 and 20 expression in intestinal metaplasia of the distal oesophagus: relationship to gastro-oesophageal reflux disease.
    Shearer C; Going J; Neilson L; Mackay C; Stuart RC
    Histopathology; 2005 Sep; 47(3):268-75. PubMed ID: 16115227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?
    Frazzoni M; Manno M; De Micheli E; Savarino V
    Dig Liver Dis; 2006 Sep; 38(9):643-8. PubMed ID: 16627016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: prevalence of Barrett's oesophagus and metaplasia at the gastro-oesophageal junction.
    Sharma P
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():48-54; discussion 61-2. PubMed ID: 15456464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
    Shapiro M; Green C; Faybush EM; Esquivel RF; Fass R
    Aliment Pharmacol Ther; 2006 Jan; 23(2):321-9. PubMed ID: 16393313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid suppression and surgical therapy for Barrett's oesophagus.
    de Jonge PJ; Spaander MC; Bruno MJ; Kuipers EJ
    Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):139-50. PubMed ID: 25743462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Gastroesophageal Reflux Disease in Asian Countries: Results of a Questionnaire Survey.
    Hojo M; Nagahara A; Hahm KB; Iwakiri R; Watanabe T; Rani AA; Zhu Q; Chan FKL; Sollano JD; Kamiya T; Yamaguchi S; Motoya S; Fock KM; Fukudo S; Kachintorn U; Suzuki H; Murakami K;
    Digestion; 2020; 101(1):66-79. PubMed ID: 31801133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial.
    Fitzgerald RC; di Pietro M; O'Donovan M; Maroni R; Muldrew B; Debiram-Beecham I; Gehrung M; Offman J; Tripathi M; Smith SG; Aigret B; Walter FM; Rubin G; ; Sasieni P
    Lancet; 2020 Aug; 396(10247):333-344. PubMed ID: 32738955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barrett's oesophagus.
    Navaratnam RM; Winslet MC
    Postgrad Med J; 1998 Nov; 74(877):653-7. PubMed ID: 10197195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of Barrett's oesophagus. A general survey.
    Petrakis IE; Sciacca V; Iascone C
    Acta Chir Belg; 2001; 101(2):53-8. PubMed ID: 11396051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does Barrett's oesophagus develop over time in patients with chronic gastro-oesophageal reflux disease?
    Stoltey J; Reeba H; Ullah N; Sabhaie P; Gerson L
    Aliment Pharmacol Ther; 2007 Jan; 25(1):83-91. PubMed ID: 17229223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004.
    Armstrong D; Marshall JK; Chiba N; Enns R; Fallone CA; Fass R; Hollingworth R; Hunt RH; Kahrilas PJ; Mayrand S; Moayyedi P; Paterson WG; Sadowski D; van Zanten SJ;
    Can J Gastroenterol; 2005 Jan; 19(1):15-35. PubMed ID: 15685294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barrett's oesophagus: epidemiology, diagnosis and clinical management.
    Whiteman DC; Kendall BJ
    Med J Aust; 2016 Oct; 205(7):317-24. PubMed ID: 27681974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barrett's metaplasia in Indian obese male patients with gastro-oesophageal reflux disease.
    Bamanikar AA; Diwan AG; Benoj DE; Bamanikar SA
    J Indian Med Assoc; 2011 Jul; 109(7):483-4. PubMed ID: 22315840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research priority setting in Barrett's oesophagus and gastro-oesophageal reflux disease.
    Britton J; Gadeke L; Lovat L; Hamdy S; Hawkey C; McLaughlin J; Ang Y
    Lancet Gastroenterol Hepatol; 2017 Nov; 2(11):824-831. PubMed ID: 28867477
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 30.